Skip to content
healthcare.dev

Fulvestrant

NDC 68462-317, Fulvestrant, injection, from GLENMARK PHARMACEUTICALS INC., USA.

Product NDC
68462-317
Status
Listed
Labeler
GLENMARK PHARMACEUTICALS INC., USA
Dosage form
INJECTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207754
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68462-317 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FULVESTRANT50 mg/mL

Pharmacologic classes

Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]

Package NDCNDC-11Package
68462-317-32684620317322 SYRINGE, GLASS in 1 CARTON (68462-317-32) / 5 mL in 1 SYRINGE, GLASS (68462-317-40)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/99cf8b69-4c23-4886-80e9-b23e348b5bd7
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=68462-317

Use it

Look up 68462-317 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68462-317 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68462-317. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.